Related Experiment Video
Updated: Mar 20, 2026
07:30
Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
Published on: May 4, 2022
3.8K
[New TNM Staging System for Thymic Malignancies].
1Dept. of Thoracic Surgery, Nagoya University Graduate School of Medicine.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|May 24, 2016
Summary
The new TNM staging system for thymic malignancies may improve recurrence-free survival analysis but does not significantly predict overall survival. This classification impacts staging for thymic epithelial tumors.
Area of Science:
- Oncology
- Thoracic Surgery
- Pathology
Context:
- The TNM classification is crucial for cancer prognosis and treatment decisions.
- A new TNM classification for thymic malignancies is proposed for the 8th edition.
- Current Masaoka-Koga staging is widely used for thymic epithelial tumors.
Purpose:
- To compare the proposed TNM classification with the Masaoka-Koga system for thymic epithelial tumors.
- To evaluate the prognostic value of the new TNM system regarding recurrence-free and overall survival.
- To assess the impact of the proposed TNM staging on patient classification.
Summary:
- 154 patients with thymic epithelial tumors were analyzed using both Masaoka-Koga and the proposed TNM staging systems.
- The proposed TNM system resulted in a significant increase in Stage I diagnoses (77.3%), downstaging Masaoka-Koga Stages II and III.
- Histologically, most low-grade thymomas (Type A, AB, B1) were classified as new Stage I.
Impact:
- The proposed TNM classification demonstrates a significant correlation between increasing stage and decreased recurrence-free survival.
- Overall survival rates did not show significant deterioration with increasing stage under the new system.
- The new TNM classification offers potential benefits for analyzing recurrence-free survival in thymic malignancies.
